ABOUT THE EVENT
Date: Tuesday, December 1, 2026 11:30am–3pm EST
Event Location: Cambridge, Massachusetts
Evonik x LEON On-site Lunch & Learn
Therapies made for a single patient, or for a small group of patients, are moving from proof of concept into the clinic. The first personalized CRISPR-based therapy, delivered with LNPs, showed what is possible.
Treating one patient is a breakthrough. Treating many, each with their own therapy, needs a model that works economically. How do we bring the cost per patient down, and what has to change in formulation, manufacturing and regulation to get there?
In this workshop, Evonik and LEON bring together speakers from academia and industry to discuss the science, the economics and the regulatory path of individualized and stratified LNP therapeutics. Expect scientific talks, open discussion and lunch.
Key learnings for participants
- Evaluate the clinical potential of personalized LNP therapeutics beyond proof of concept
- Understand how formulation and manufacturing innovations can enable scalable individualized treatments
- Identify key economic factors that will determine commercial feasibility and patient access
- Gain perspective on the evolving regulatory environment for personalized and stratified therapies